当前位置:首页 - 行情中心 - 尔康制药(300267) - 财务分析 - 现金流量表

尔康制药

(300267)

  

流通市值:41.96亿  总市值:60.85亿
流通股本:14.22亿   总股本:20.63亿

现金流量表

报告期2026-09-302026-06-302026-03-312025-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金985,885,744.61518,203,459.22239,409,879.331,148,869,063.32
  收到的税费返还8,040,410.527,192,033.442,923,821.067,788,046.81
  收到其他与经营活动有关的现金73,632,679.3810,556,731.8321,066,912.82335,790,016.09
  经营活动现金流入小计1,067,558,834.51535,952,224.49263,400,613.211,492,447,126.22
  购买商品、接受劳务支付的现金733,260,491.46513,575,360.73172,747,428.58620,209,903.93
  支付给职工以及为职工支付的现金128,419,971.8487,453,877.0549,507,464.81152,239,583.9
  支付的各项税费34,795,984.1323,082,698.415,908,780.0152,051,865.56
  支付其他与经营活动有关的现金145,409,323.165,889,807.0735,155,081.66410,260,801.52
  经营活动现金流出小计1,041,885,770.53690,001,743.25273,318,755.061,234,762,154.91
  经营活动产生的现金流量净额25,673,063.98-154,049,518.76-9,918,141.85257,684,971.31
二、投资活动产生的现金流量:
  收回投资收到的现金330,000,000310,000,000170,000,0001,110,000,000
  取得投资收益收到的现金3,711,120.19524,826.5323,244.33,775,387.98
  处置固定资产、无形资产和其他长期资产收回的现金净额1,567,062.941,525,561.4115,672.971,737,885.73
  投资活动现金流入小计335,278,183.13312,050,387.91170,338,917.271,115,513,273.71
  购建固定资产、无形资产和其他长期资产支付的现金180,830,205.3278,807,814.0134,797,831.2163,980,195.38
  投资支付的现金240,000,000240,000,000170,000,0001,080,000,000
  支付其他与投资活动有关的现金105,720.5719,066.24--
  投资活动现金流出小计420,935,925.89318,826,880.25204,797,831.21,243,980,195.38
  投资活动产生的现金流量净额-85,657,742.76-6,776,492.34-34,458,913.93-128,466,921.67
三、筹资活动产生的现金流量:
  吸收投资收到的现金750,000750,000750,000-
  取得借款收到的现金696,679,109.98472,200,000269,000,000671,337,821
  收到其他与筹资活动有关的现金399,662,500200,000,00086,000,000278,600,000
  筹资活动现金流入小计1,097,091,609.98672,950,000355,750,000949,937,821
  偿还债务支付的现金576,987,821334,397,821136,000,000597,700,000
  分配股利、利润或偿付利息支付的现金8,219,778.985,286,155.573,329,283.3311,092,503.99
  支付其他与筹资活动有关的现金455,845,295.42323,349,224.71173,739,273.36372,684,503.86
  筹资活动现金流出小计1,041,052,895.4663,033,201.28313,068,556.69981,477,007.85
  筹资活动产生的现金流量净额56,038,714.589,916,798.7242,681,443.31-31,539,186.85
四、汇率变动对现金及现金等价物的影响-2,552,831.9-382,825.31-545,998.75-3,364,598.62
五、现金及现金等价物净增加额-6,498,796.1-151,292,037.69-2,241,611.2294,314,264.17
  加:期初现金及现金等价物余额584,223,288.95584,223,288.95584,223,288.95489,909,024.78
  期末现金及现金等价物余额577,724,492.85432,931,251.26581,981,677.73584,223,288.95
补充资料:
  净利润-33,887,289.91--399,311,259.91
  资产减值准备-2,813,744.34-356,982,143.17
  固定资产和投资性房地产折旧-65,882,512.94-151,579,107.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-65,882,512.94-151,579,107.31
  无形资产摊销-9,590,514.8-22,909,486.63
  长期待摊费用摊销-1,624,214.86-3,445,357.31
  处置固定资产、无形资产和其他长期资产的损失-278,275.91--313,748.98
  固定资产报废损失-478.9-572,037.41
  财务费用-5,896,134.82-8,385,944.34
  投资损失--300,898.51-18,168,794.63
  递延所得税-5,809,832.34-29,567,995.37
  其中:递延所得税资产减少-7,413,473.53-30,143,847.78
    递延所得税负债增加--1,603,641.19--575,852.41
  存货的减少--240,035,728.11-42,034,563.72
  经营性应收项目的减少--27,596,187.9-2,482,707.86
  经营性应付项目的增加-4,388,365.76-27,712,497.51
  其他--19,926,316.34--12,991,577.09
  现金的期末余额-432,931,251.26-584,223,288.95
  减:现金的期初余额-584,223,288.95-489,909,024.78
  现金及现金等价物的净增加额--151,292,037.69-94,314,264.17
公告日期2026-10-292026-08-272026-04-242026-04-23
审计意见(境内)标准无保留意见
TOP↑